Neurogene NGNE
NASDAQ NGNE
$26.00 +0.60 (+2.36%)
As of: Oct 21, 2026 · 3:54 PM EDT

Neurogene (NGNE) EBITDA Margin (2019 - 2024)

Updated

Neurogene (NGNE) posted EBITDA Margin of -8584.32% for FY2024.

Analysis

Neurogene (NGNE) EBITDA Margin (2019 - 2024) Analysis & Trends

  • Annual EBITDA Margin shows a five-year change of -8577.26 percentage points (FY2019 to FY2024).
  • The FY2024 figure stands as the highest annual EBITDA Margin since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn 35.95%
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn 49.01%
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn -
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn 33.11%
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn -124.26%
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn 39.16%
10 Neurogene 591.20 Mn -411.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -2,088.32%
Mar 31, 2023 -1,292.80%
Dec 31, 2022 -1,184.31%
Sep 30, 2022 -2,376.74%
Jun 30, 2022 -7,944.33%
Mar 31, 2022 -115,030.77%
Dec 31, 2021 -295,680.00%
Sep 30, 2021 -251,600.00%
Sep 30, 2019 -5.94%
API Access

Neurogene EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NGNE&period=max&api_key=YOUR_API_KEY